Heart and Vascular Clinical Trial - Medtronic Spyral

Status:

In Process (Study opening soon)

ClinicalTrials.gov:

NCT03433274

The purpose of this study is to test the hypothesis that renal denervaton decreases blood pressure and is save when studied in the absence of antihypertensive medications.

Drug

Device: Symplicity Spyral™ multi-electrode renal denervation system Procedure: Sham Procedure

Trial Type

Interventional

Age Range

18 years or older

Condition

Cardiovascular Heart and vascular Hypertension Heart Disease

Keywords

Symplicity Spyral | Medtronic Spyral | Hypertension | Heart Disease